ConductScience.org, home

Paper17519123

How to treat hypertension in patients with peripheral artery disease.

Clement DL and 1 other. Curr Hypertens Rep, 2007. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. How to treat hypertension in patients with peripheral artery disease. Papers, record 17519123. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17519123

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
How to treat hypertension in patients with peripheral artery disease.
PubMed
Journal
Curr Hypertens Rep
PubMed
Year
2007
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.14
iCite
Revised in PubMed
2022-07-16
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Clement DLDenis L
2Debuyzere MLMarc L

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HypertensionMajor topic
Peripheral Vascular DiseasesMajor topic
Antihypertensive Agents
Cardiovascular Diseases
Humans
Risk Factors
Risk Reduction Behavior

Source PubMed

Download CSV of topics

References33

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12866047Effect of beta-adrenergic blockers on the peripheral circulation in patients with peripheral vascular disease.Circulation1985https://conductscience.org/library/papers/2866047PubMed
23987540Effect of felodipine and metoprolol on muscle and skin arteries in hypertensive patients.Drugs1985https://conductscience.org/library/papers/3987540PubMed
317161053
Antihypertensive therapy and regression of coronary artery disease: insights from the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis (CAMELOT) and Norvasc for Regression of Manifest Atherosclerotic Lesions by Intravascular Sonographic Evaluation (NORMALISE) trials.
Am Heart J2006https://conductscience.org/library/papers/17161053PubMed
416549646
ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.
Circulation2006https://conductscience.org/library/papers/16549646PubMed
516545650Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease.J Am Coll Cardiol2006https://conductscience.org/library/papers/16545650PubMed
616076834Temporal trends in the incidence of intermittent claudication from 1950 to 1999.Am J Epidemiol2005https://conductscience.org/library/papers/16076834PubMed
710905794A clinical approach to the management of the patient with coronary (Co) and/or carotid (Ca) artery disease who presents with leg ischaemia (Lis).Int Angiol2000https://conductscience.org/library/papers/10905794PubMed
811130523
Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration.
Lancet2000https://conductscience.org/library/papers/11130523PubMed
916154016
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.
Lancet2005https://conductscience.org/library/papers/16154016PubMed
1012114036MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.Lancet2002https://conductscience.org/library/papers/12114036PubMed
1111786451Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.BMJ2002https://conductscience.org/library/papers/11786451PubMed
121729621Mortality over a period of 10 years in patients with peripheral arterial disease.N Engl J Med1992https://conductscience.org/library/papers/1729621PubMed
139400557Mortality over four years in SHEP participants with a low ankle-arm index.J Am Geriatr Soc1997https://conductscience.org/library/papers/9400557PubMed
1415579058Hypertension in peripheral arterial disease.Curr Pharm Des2004https://conductscience.org/library/papers/15579058PubMed
1512409970Benefit and harm of low-dose aspirin in well-treated hypertensives at different baseline cardiovascular risk.J Hypertens2002https://conductscience.org/library/papers/12409970PubMed
1616531616Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events.N Engl J Med2006https://conductscience.org/library/papers/16531616PubMed
179297994Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.Lancet1997https://conductscience.org/library/papers/9297994PubMed
1815153815A clinical approach to the management of a patient with suspected renovascular disease who presents with leg ischemia.Int Angiol2003https://conductscience.org/library/papers/15153815PubMed
1910666287Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC).J Vasc Surg2000https://conductscience.org/library/papers/10666287PubMed
201524519Vascular event rates in patients with atherosclerotic cerebrovascular disease.Arch Neurol1992https://conductscience.org/library/papers/1524519PubMed

See all 33 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
28575088Effect of blood pressure lowering medications on leg ischemia in peripheral artery disease patients: A meta-analysis of randomised controlled trials.PLoS One2017https://conductscience.org/library/papers/28575088PubMed
24307487Treatment of hypertension in peripheral arterial disease.Cochrane Database Syst Rev2013https://conductscience.org/library/papers/24307487PubMed
19602328Treatment of hypertension in patients with peripheral arterial disease: an update.Curr Hypertens Rep2009https://conductscience.org/library/papers/19602328PubMed
19276131Naftidrofuryl for intermittent claudication: meta-analysis based on individual patient data.BMJ2009https://conductscience.org/library/papers/19276131PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17519123

GET https://conductscience.org/api/papers/v1/17519123/references?page=2